JP2024532957A5 - - Google Patents

Info

Publication number
JP2024532957A5
JP2024532957A5 JP2024533929A JP2024533929A JP2024532957A5 JP 2024532957 A5 JP2024532957 A5 JP 2024532957A5 JP 2024533929 A JP2024533929 A JP 2024533929A JP 2024533929 A JP2024533929 A JP 2024533929A JP 2024532957 A5 JP2024532957 A5 JP 2024532957A5
Authority
JP
Japan
Prior art keywords
patient
liver
fibrosis
elf
score
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024533929A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532957A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/040227 external-priority patent/WO2023018972A1/en
Publication of JP2024532957A publication Critical patent/JP2024532957A/ja
Publication of JP2024532957A5 publication Critical patent/JP2024532957A5/ja
Pending legal-status Critical Current

Links

JP2024533929A 2021-08-13 2022-08-12 ウデナフィル組成物を用いた線維肝状態を処置する方法および組成物 Pending JP2024532957A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163233133P 2021-08-13 2021-08-13
US63/233,133 2021-08-13
PCT/US2022/040227 WO2023018972A1 (en) 2021-08-13 2022-08-12 Methods and compositions for treating fibrotic liver conditions, using udenafil compositions

Publications (2)

Publication Number Publication Date
JP2024532957A JP2024532957A (ja) 2024-09-10
JP2024532957A5 true JP2024532957A5 (cg-RX-API-DMAC7.html) 2025-08-19

Family

ID=83355014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024533929A Pending JP2024532957A (ja) 2021-08-13 2022-08-12 ウデナフィル組成物を用いた線維肝状態を処置する方法および組成物

Country Status (7)

Country Link
US (2) US20230218622A1 (cg-RX-API-DMAC7.html)
EP (1) EP4384176A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024532957A (cg-RX-API-DMAC7.html)
AU (1) AU2022325803A1 (cg-RX-API-DMAC7.html)
CA (1) CA3229274A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024001972A (cg-RX-API-DMAC7.html)
WO (1) WO2023018972A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12396708B2 (en) * 2024-01-08 2025-08-26 Echosens Sa Method for determining an index for assessing a cardiac function of a subject
EP4582017A1 (en) * 2024-01-08 2025-07-09 Echosens Method for determining an index for assessing a cardiac function of a subject

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0202254D0 (en) * 2002-01-31 2002-03-20 Pfizer Ltd Prevention of scarring
EP1888074B1 (en) * 2005-06-10 2011-12-21 Dong-A Pharmaceutical Co., Ltd. Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidine derivative
MX390977B (es) 2014-08-12 2025-03-21 Mezzion Pharma Co Ltd Metodos para mejorar el rendimiento miocardico en pacientes con cirugia de fontan que utilizan composiciones de udenafilo

Similar Documents

Publication Publication Date Title
Agabiti Rosei et al. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study
AU2017327383A1 (en) Method of reducing thyroid-associated side effects
JP2001199882A (ja) 感冒・鼻炎用組成物
EP2988750B9 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
JP2025515491A5 (cg-RX-API-DMAC7.html)
CN108619138B (zh) 血管紧张素受体拮抗剂和脑啡肽酶抑制剂的复合物及其用途
JPH0575729B2 (cg-RX-API-DMAC7.html)
JP2025118624A (ja) ウデナフィル組成物を用いた単心室心疾患における運動能力、単心室性能、および心筋性能指数(mpi)を改善する方法
KR100907938B1 (ko) 발기 기능장애의 치료를 위한 알카노일 l-카르니틴의 용도
DE69812028T2 (de) Creatine Derivate für Asthma
WO2008057464A2 (en) Compositions and methods for improving the bioavailability of liothyronine
JP2022518527A (ja) パーキンソン病の患者を治療する方法
JP7366108B2 (ja) ロキソプロフェン又はその塩及びビタミンb12類を含有する経口用医薬組成物
JP2025505187A5 (cg-RX-API-DMAC7.html)
JPS60215635A (ja) アザプロパゾンを含有する医薬品製剤
US10758517B2 (en) mPGES-1 inhibitor for the treatment of osteoarthritis pain
JP4702054B2 (ja) 増強剤
KR20180038003A (ko) 수축력 저하 수반성 배뇨근 과활동 개선제
JPH08253415A (ja) 抗動脈硬化治療剤
WO2022004867A1 (ja) 排尿症状治療剤
US20230270724A1 (en) PDE3 inhibitors for treating viral infections
CN111973579A (zh) 丁酸盐在制备治疗或预防肾损伤的药物中的应用
JP5923044B2 (ja) 活性成分としてl−カルニチンまたはプロピオニルl−カルニチンを含む慢性静脈不全の予防または治療のための併用組成物
HUP0201650A2 (hu) Amino-tetralin-származékok alkalmazása szív- és érrendszeri betegségek gyógykezelésére használható gyógyszerek előállítására
JP2025505632A5 (cg-RX-API-DMAC7.html)